...
首页> 外文期刊>Planta medica: Natural products and medicinal plant research >New guaiane, megastigmane and eudesmane-type sesquiterpenoids and anti-inflammatory constituents from Youngia japonica.
【24h】

New guaiane, megastigmane and eudesmane-type sesquiterpenoids and anti-inflammatory constituents from Youngia japonica.

机译:扬子植物中的新愈创木脂,超大柱石和奥德斯曼型倍半萜和抗炎成分。

获取原文
获取原文并翻译 | 示例
           

摘要

Eleven sesquiterpenoids have been isolated from the whole plants of Youngia japonica (Asteraceae). Among these sesquiterpenoids, five were identified as new compounds on the basis of spectroscopic methods and chemical analysis. Their structures were 3-oxo-8alpha-(4-hydoxyphenyl)acetoxy-10(14),11(13)-guaiadien-12,6-olide ( 1), 3beta-[3-(4-hydroxyphenyl)acetyl-beta- D-glucopyranosyloxy]-8alpha-hydroxy-4(15),10(14),11(13)-guaiatrien-12,6-ol ide ( 2), 3beta-[3-(4-hydroxyphenyl)acetyl-beta- D-glucopyranosyloxy]-4(15),10(14),11(13)-guaiatrien-12,6-olide ( 3), 3alpha,5beta,6alpha-trihydroxy-4alpha-(beta- D-glucopyranosyloxy)-7-megastigmen-9-one ( 4), and 3alpha-(beta- D-glucopyranosyloxy)-4(15),11(13)-eudesmadien-12-oic acid ( 5). The three known components 3beta-(beta- D-glucopyranosyloxy)-8alpha-(4-hydroxyphenyl)acetoxy-4(15),10(14),11(13)-g uaiatrien-12,6-olide ( 8), 3beta-(beta- D-glucopyranosyloxy)-4(15),10(14),11 (13)-guaiatrien-12,6-olide ( 9), and 3alpha-hydroxy-4alpha-(beta- D-glucopyranosyloxy)-5,7-megastigmadien-9-one ( 11) showed inhibitory activity against the proliferation of T and B lymphocytes of mice in vitro at concentrations of 1 x 10 ( - 7), 1 x 10 ( - 6), and/or 1 x 10 ( - 5) M without obvious cytotoxicity. Compound 9, the major component of the plant extract, exhibited weak anti-inflammatory activity at a dosage of 50 mg/kg ( p. o.) in in vivo anti-inflammatory experiments of mice.
机译:从洋槐(菊科)的整个植物中分离出了十一种倍半萜。根据光谱方法和化学分析,在这些倍半萜中,有五种被鉴定为新化合物。它们的结构是3-氧代-8α-(4-羟基苯基)乙酰氧基-10(14),11(13)-愈创木酚-12,6-内酰胺(1),3beta- [3-(4-羟基苯基)乙酰基-beta -D-吡喃葡萄糖基氧基] -8alpha-羟基-4(15),10(14),11(13)-愈创木烯-12,6-醇化物(2),3beta- [3-(4-羟苯基)乙酰基-beta -D-吡喃葡萄糖基氧基] -4(15),10(14),11(13)-愈创木烯-12,6-油化物(3),3alpha,5beta,6alpha-三羟基-4alpha-(beta- D-吡喃葡萄糖基氧基)- 7-megastigmen-9-1(4)和3alpha-(β-D-吡喃葡萄糖基氧基)-4(15),11(13)-eudesmadien-12-oic acid(5)。三种已知成分3β-(β-D-吡喃葡萄糖基氧基)-8α-(4-羟基苯基)乙酰氧基-4(15),10(14),11(13)-g uaiatrien-12,6-olide(8), 3β-(β-D-吡喃葡糖基氧基)-4(15),10(14),11(13)-愈创木烯-12,6-油化物(9)和3α-羟基-4α-(β-D-吡喃葡糖基氧基) -5,7-megastigmadien-9-one(11)在1 x 10(-7),1 x 10(-6)和/或浓度下对小鼠T和B淋巴细胞的增殖具有抑制活性1 x 10(-5)M,无明显细胞毒性。在小鼠体内抗炎实验中,植物提取物的主要成分化合物9在50 mg / kg(p。o。)的剂量下显示出较弱的抗炎活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号